WHO recommends Merck Covid pill for non-severe, at-risk patients
However, young and healthy patients, including children, and pregnant and breastfeeding women should not be given the drug due to 'potential harms', WHO experts say.
Merck’s at-home antiviral Covid pill gets US nod
Merck's drug has been authorised to treat mild-to-moderate Covid-19 in adults who are at risk for severe disease.
No articles found.